Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins

Stopped Research was completed before January 18, 2017, \& does not meet the Applicable Clinical Trial requirement to register \& report results per the guidance provided in "Clinical Trials Registration \& Results Information Submission" dated 09/21/2016.

Conditions

• Cavernous Angioma, Familial
• Cerebral Cavernous Malformations
• Cerebral Cavernous Hemangioma

Interventions

• DRUG: Simvastatin

Sponsor

University of New Mexico

Collaborators

• [object Object]
• [object Object]